Spots Global Cancer Trial Database for oral cavity carcinoma

Every month we try and update this database with for oral cavity carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy	NCT04870762	Head and Neck C... Malignant Parot... Maxillary Sinus... Nasal Cavity Ca... Oral Cavity Car... Tongue Carcinom... Tonsillar Carci...	Best Practice Medical Device ...	18 Years -	M.D. Anderson Cancer Center
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma	NCT03422536	Head and Neck B... Recurrent Head ... Recurrent Oroph... Squamous Cell C... Stage IV Squamo... Stage IV Squamo... Stage IV Nasoph... Stage IV Oropha... Stage IVA Lip a... Stage IVA Nasal... Stage IVA Nasop... Stage IVA Oroph... Stage IVB Lip a... Stage IVB Nasal... Stage IVB Nasop... Stage IVB Oroph... Stage IVC Lip a... Stage IVC Nasal... Stage IVC Nasop... Stage IVC Oroph... Head and Neck C... Oropharyngeal C... HNSCC Stage IV Lip an...	Cetuximab Ficlatuzumab	18 Years -	University of Arizona
A Trial of Photodynamic Therapy With HPPH for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx	NCT01140178	Dysplasia Carcinoma of th... Carcinoma of th...	HPPH	18 Years -	Roswell Park Cancer Institute
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors	NCT02834013	Acinar Cell Car... Adenoid Cystic ... Adrenal Cortica... Adrenal Gland P... Anal Canal Neur... Anal Canal Undi... Angiosarcoma Apocrine Neopla... Appendix Mucino... Bartholin Gland... Basal Cell Carc... Bladder Adenoca... Breast Metaplas... Cervical Adenoc... Cholangiocarcin... Chordoma Colorectal Squa... Desmoid Fibroma... Endometrial Tra... Endometrioid Ad... Esophageal Neur... Esophageal Undi... Extrahepatic Bi... Extramammary Pa... Fallopian Tube ... Fallopian Tube ... Fibromyxoid Tum... Gallbladder Car... Gastric Neuroen... Gastric Squamou... Gastric Undiffe... Gastrointestina... Gestational Tro... Giant Cell Carc... Human Papilloma... Intestinal Neur... Intrahepatic Ch... Lung Neuroendoc... Lung Sarcomatoi... Major Salivary ... Malignant Odont... Malignant Perip... Malignant Solid... Malignant Testi... Metastatic Mali... Metastatic Pitu... Minimally Invas... Mixed Mesoderma... Mucinous Adenoc... Mucinous Cystad... Nasal Cavity Ad... Nasal Cavity Ca... Nasopharyngeal ... Nasopharyngeal ... Nasopharyngeal ... Oral Cavity Car... Oropharyngeal U... Ovarian Adenoca... Ovarian Germ Ce... Ovarian Mucinou... Ovarian Squamou... Ovarian Transit... Pancreatic Acin... Pancreatic Neur... Paraganglioma Paranasal Sinus... Paranasal Sinus... Parathyroid Gla... PEComa Penile Squamous... Peritoneal Meso... Placental Chori... Primary Periton... Pseudomyxoma Pe... Rare Disorder Scrotal Squamou... Seminal Vesicle... Seminoma Serous Cystaden... Small Intestina... Small Intestina... Spindle Cell Ne... Teratoma With S... Testicular Non-... Thyroid Gland C... Tracheal Carcin... Transitional Ce... Ureter Adenocar... Ureter Squamous... Urethral Adenoc... Urethral Squamo... Vaginal Adenoca... Vaginal Squamou... Vulvar Carcinom...	Biospecimen Col... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion	NCT02581137	Erythroplakia Hyperplasia Oral Cavity Car... Oral Leukoplaki...	Laboratory Biom... Metformin Hydro...	18 Years -	National Cancer Institute (NCI)
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer	NCT04162873	Clinical Stage ... Clinical Stage ... Nasal Cavity an... Oral Cavity Car... Pathologic Stag... Pathologic Stag... Recurrent Hypop... Recurrent Laryn... Recurrent Nasal... Recurrent Oral ... Recurrent Oroph... Stage III Hypop... Stage III Laryn... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Oropha... Stage IVA Hypop... Stage IVA Laryn... Stage IVA Oroph... Stage IVB Hypop... Stage IVB Laryn... Stage IVB Oroph... Stage IVC Hypop... Stage IVC Laryn... Stage IVC Oroph...	Celecoxib Placebo Quality-of-Life... Questionnaire A...	18 Years -	University of Utah
Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer	NCT00780312	Oral Cavity Car... Oropharyngeal C... Adverse Effect ... Trismus	physiotherapy	18 Years -	Rigshospitalet, Denmark
Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia	NCT02882282	Oral Cavity Car... Oral Intraepith...	Laboratory Biom... Patient Observa... Pembrolizumab	18 Years -	M.D. Anderson Cancer Center
HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers	NCT05075980	Head and Neck C... Head and Neck C... Hypopharyngeal ... Laryngeal Carci... Metastatic Mali... Nasal Cavity Ca... Oral Cavity Car... Oropharyngeal C... Paranasal Sinus... Salivary Gland ... Cutaneous Squam... Locally Advance...	Cisplatin Intensity-Modul... Quality-of-Life... Questionnaire A... Computed Tomogr... Magnetic Resona... Positron Emissi... Biospecimen Col...	18 Years -	Mayo Clinic
Role of Acetaldehyde in the Development of Oral Cancer	NCT05973656	Alcohol-Related... Fanconi Anemia Oral Cavity Car...	Alcohol Biospecimen Col... Breath Test	18 Years - 45 Years	Masonic Cancer Center, University of Minnesota
Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment	NCT04788264	Head and Neck C... Hypopharyngeal ... Laryngeal Carci... Maxillary Sinus... Oral Cavity Car... Oropharyngeal C... Paranasal Sinus... Sinonasal Carci... Stage I Larynge... Stage II Laryng... Stage III Laryn... Stage IV Laryng... Stage IVA Laryn... Stage IVB Laryn... Stage IVC Laryn... Lung Carcinoma	Medical Device ... Consultation Exercise Interv... Behavioral Inte... Questionnaire A... Quality of Life...	18 Years -	Thomas Jefferson University
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma	NCT03422536	Head and Neck B... Recurrent Head ... Recurrent Oroph... Squamous Cell C... Stage IV Squamo... Stage IV Squamo... Stage IV Nasoph... Stage IV Oropha... Stage IVA Lip a... Stage IVA Nasal... Stage IVA Nasop... Stage IVA Oroph... Stage IVB Lip a... Stage IVB Nasal... Stage IVB Nasop... Stage IVB Oroph... Stage IVC Lip a... Stage IVC Nasal... Stage IVC Nasop... Stage IVC Oroph... Head and Neck C... Oropharyngeal C... HNSCC Stage IV Lip an...	Cetuximab Ficlatuzumab	18 Years -	University of Arizona

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: